ITM2B and neoplasm: In the Renca cell‐derived orthotopic renal cell carcinoma mouse model, ITM2B knockdown retarded tumor growth (Figure 1F) through the inhibition of tumor cell proliferation, as indicated by Ki67 immunostaining (Figure 1G).